Inactive Instrument

Alexandria Pharma. & Chemical Industries Stock price Egyptian Exchange

Equities

Pharmaceuticals

End-of-day quote Egyptian Exchange
- EGP 0.00% Intraday chart for Alexandria Pharma. & Chemical Industries
Sales 2022 1.22B 25.7M Sales 2023 1.48B 31.35M Capitalization 691M 14.59M
Net income 2022 129M 2.72M Net income 2023 126M 2.66M EV / Sales 2022 0.32 x
Net cash position 2022 145M 3.05M Net cash position 2023 78.48M 1.66M EV / Sales 2023 0.41 x
P/E ratio 2022
4.1 x
P/E ratio 2023
5.47 x
Employees -
Yield 2022 *
-
Yield 2023
9.41%
Free-Float 19.8%
More Fundamentals * Assessed data
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2022 CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2021 CI
VAlexandria Pharmaceuticals Announces Consolidated Earnings Results for the Six Months Ended December 31, 2020 CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Announces Earnings Results for the Year Ended on 30 June 2020 CI
Alexandria Pharmaceuticals Announces Earnings Results for the Year Ended June 30, 2019 CI
Alexandria Co. for Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2018 CI
Alexandria Co. for Pharmaceuticals & Chemical Industries Reports Reviewed Earnings Results for the Period Ended December 31, 2018 CI
Alexandria Pharmaceuticals Reports Earnings Results for the Three Months Ended September 30, 2018 CI
Alexandria Pharmaceuticals Announces Audited Earnings Results for the Year Ended June 30, 2018 CI
Alexandria Pharmaceuticals Announces Earnings Results for the Nine Months Ended March 31, 2018 CI
Alexandria Pharmaceuticals Reports Earnings Results for the Half Year Ended December 31, 2017 CI
Alexandria Pharmaceuticals Announces Audited Earnings Results for the Year Ended September 30, 2017 CI
Alexandria Pharmaceuticals Announces Audited Earnings Results for the Year Ended June 30, 2017 CI
More news
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Administrative Officer - -
Members of the board TitleAgeSince
Chairman - -
Director/Board Member - -
Chief Executive Officer - -
More insiders
Alexandria Co. for Pharmaceuticals & Chemical Industries SAE specializes in developing, manufacturing and marketing pharmaceutical products for the treatment of inflammatory, infectious, pulmonary, dermatological, cardiovascular, allergic, epileptic, gastrointestinal diseases, etc. The group also provides veterinary and medical products (adhesive tape, gauze compresses, gloves, traction kits, etc.).
More about the company
  1. Stock
  2. Equities
  3. Stock Alexandria Co. For Pharmaceuticals & Chemical Industries
  4. Stock Alexandria Pharma. & Chemical Industries - Egyptian Exchange